Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03498651 · ClinicalTrials.gov registry record · Phase 2
Interpretation Training to Reduce Anxiety: Evaluating Technology-based Delivery Models and Methods to Reduce Attrition
A Phase 2 study of Anxiety, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,748
- Enrollment target
- 1
- Study location
NCT03498651 is a Phase 2 study of Anxiety that has completed, run by University of Virginia. The registered enrollment target is 1,748 participants, above the 435-participant average among 364 other Anxiety trials with a reported enrollment target (302% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03498651, a Phase 2 study of Anxiety, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,748 participants
- Enrollment target
- 1
- Study location
Study Summary
The project aims to compare effectiveness and target engagement of CBM-I delivered via computer vs. mobile phone, and test if adding minimal human contact for participants at risk of dropout improves retention and outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Coaching
- BEHAVIORAL Cognitive Bias Modification - Interpretation training
- BEHAVIORAL Online psychoeducation about anxiety
Study Locations (1)
Virginia
- MindTrails web site: https://mindtrails.virginia.edu/ (thru Univ. of Virginia) - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,748 participants |
| Start Date | 2019-01-20 |
| Est. Completion | 2020-12-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03498651
The ClinicalTrials.gov registry entry for NCT03498651 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,748 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 435-participant average among 364 other Anxiety trials with a reported enrollment target (302% higher). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 3 interventions - of which Coaching is the first listed.
NCT03498651 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT03498651 about?
NCT03498651 is a clinical study titled "Interpretation Training to Reduce Anxiety: Evaluating Technology-based Delivery Models and Methods to Reduce Attrition". The project aims to compare effectiveness and target engagement of CBM-I delivered via computer vs. mobile phone, and test if adding minimal human contact for participants at risk of dropout improves retention and outcomes.
What is the current status of trial NCT03498651?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,748 participants. The study started on 2019-01-20. Estimated completion is 2020-12-03.
What conditions does trial NCT03498651 study?
This clinical trial studies the following conditions: Anxiety.
What interventions are being tested in trial NCT03498651?
The interventions under investigation include: Coaching (BEHAVIORAL), Cognitive Bias Modification - Interpretation training (BEHAVIORAL), Online psychoeducation about anxiety (BEHAVIORAL).
Who is sponsoring clinical trial NCT03498651?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03498651 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Use of CBD in the Treatment of Anxiety
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.